http://www.madrigalpharma.com
Madrigal Pharmaceuticals, Inc. Company Intro
Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.
Industry
Healthcare
Madrigal Pharmaceuticals, Inc. Headquaters
Four Tower Bridge
West Conshohocken,19428
United States
Madrigal Pharmaceuticals, Inc. Share price
17 May 2023 13:30 GMT
$280.82
-11.38 (-3.89 %)
Madrigal Pharmaceuticals, Inc. Market cap
$5.311 B
WMC RANKING
2024
Madrigal Pharmaceuticals, Inc. # 483
BiotechnologyLatest Madrigal Pharmaceuticals, Inc. News
12 Feb 2024
FANG, VTNR major energy gainers; MTR major loser
An analysis of the stock market shows gains for Diamondback Energy and Vertex Energy, while Mesa Royalty Trust faces losses.
12 Feb 2024
U.S. federal budget deficit narrows more than expected in January
Khaichuin Sim/Moment via Getty Images The U.S. government spent $22.0B more than it earned in January, smaller than the $39.3B expected deficit and the...
12 Feb 2024
Takeda gets FDA approval for eosinophilic esophagitis drug (NYSE:TAK)
Takeda (TAK) said it has received FDA approval for its drug Eohilia for the treatment of eosinophilic esophagitis in patients 11 years and older.
WMC Market Score
WMC Market to Revenue Score
Madrigal Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Madrigal Pharmaceuticals, Inc. | USD | $0 | $221,647 | $-218,655 | $53,110B | 483 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Madrigal Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
Madrigal Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
Madrigal Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Madrigal Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Madrigal Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Madrigal Pharmaceuticals, Inc. | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
